Oaktree Acquisition Corp. Iii Life Sciences (OACCW) Stock Price & Analysis
Oaktree Acquisition Corp. Iii Life Sciences (OACCW) rose 24.29% to USD 0.87 as of June 11, 2026 at 04:00 UTC, according to Nexqual real-time market data.
OACCW last closed at USD 0.7; the session ranged USD 0.87–0.89 on volume of 2,512 shares. Market capitalization is —, with a 52-week range of USD 0.87–0.89 (NGM). Source: Nexqual, June 11, 2026 at 04:00 UTC.
Key Statistics (as of June 11, 2026 at 04:00 UTC)
| Price | USD 0.87 |
|---|---|
| Change | ▲ 24.29% (up) |
| Previous Close | USD 0.7 |
| Open | USD 0.99 |
| Day Range | USD 0.87 – 0.89 |
| 52-Week Range | USD 0.87 – 0.89 |
| Volume | 2,512 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (OACCW)
Nexqual's technical model rates OACCW "SELL" based on 2 bullish and 4 bearish signals across 67 daily candles, as of June 11, 2026 at 04:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0.78) |
| MACD | 0 (negative) |
Analyst Ratings (OACCW)
Wall Street analysts rate OACCW "None", per Nexqual as of June 11, 2026 at 04:00 UTC.
| Consensus Rating | None |
|---|
Earnings (OACCW)
Source: Nexqual, June 11, 2026 at 04:00 UTC.
Financials & Fundamentals (OACCW)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.87 |
| Total Cash | $1.28M |
| Total Debt | $11,824 |
Source: Nexqual, June 11, 2026 at 04:00 UTC.
Financial Health Score (OACCW)
Nexqual rates Oaktree Acquisition Corp. Iii Life Sciences's overall financial health "Weak" across five dimensions, as of June 11, 2026 at 04:00 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $1M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$505K |
| Efficiency | Mixed — No data |
Ownership (OACCW)
| Float | 18.37M |
|---|
Source: Nexqual, June 11, 2026 at 04:00 UTC.
Leadership (OACCW)
Oaktree Acquisition Corp. Iii Life Sciences is led by Zaid Pardesi (age 42), CEO & Director, per Nexqual as of June 11, 2026 at 04:00 UTC.
| CEO & Director | Zaid Pardesi (age 42) |
|---|---|
| CFO, Principal Accounting & Principal Financial Officer | George A. Martinez (age 40) |
Major Backers & Investors (OACCW)
Notable institutional backers of Oaktree Acquisition Corp. Iii Life Sciences include Healthcare of Ontario Pension Plan Trust Fund, AQR Arbitrage LLC, Toronto Dominion Bank, according to Nexqual as of June 11, 2026 at 04:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 9.42% |
| AQR Arbitrage LLC | 7.81% |
| Toronto Dominion Bank | 4.8% |
| Walleye Capital LLC | 4.7% |
| Decagon Asset Management LLP | 4.51% |
| Boussard & Gavaudan Investment Management LLP | 4.16% |
| JPMorgan | 4.02% |
| Weiss Asset Management Lp | 4.01% |
Source: Nexqual, June 11, 2026 at 04:00 UTC.
From Oaktree Acquisition Corp. Iii Life Sciences's Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- III Life Sciences does not have significant operations.
- The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
- It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LPAAW | Launch One Acquisition Corp. Wa | USD 0.21 | ▲ 28.05% |
| OACC | Oaktree Acquisition Corp. III L | USD 10.66 | ▲ 0.09% |
| NPACW | New Providence Acquisition Corp | USD 0.32 | ▼ 21.95% |
| SIMAW | SIM Acquisition Corp. I Warrant | USD 0.25 | ▼ 34.21% |
| LPBBW | Launch Two Acquisition Corp. Wa | USD 0.16 | ▼ 30.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 04:00 UTC. This page is informational and not investment advice.